NCT00678392 · Interventional trial
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
Overall registry status Completed
Phase 3
Conditions Kidney Neoplasms
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory